HK Stock Connect Daily Report: Hang Seng Index Edged Down 0.17%; YUNJI, Listed for Less Than 11 Months Before Gaining Stock Connect Access, Fell 16.44% -20260909

NewTimeSpace · 2026/09/09 18:13 · By Zeyu Wu

On September 9, 2026, the three major Hong Kong indices continued to weaken, with the Hang Seng Index edging down 0.17%, the Hang Seng TECH Index down 0.76%, and the Hang Seng China Enterprises Index down 0.34%. The Hang Seng Index's total market turnover was 204.9 billion HKD. Amid accelerated AI iteration, XIZHI TECH-P surged 19.19%; SHINEWAY PHARM surged 11.38%, as the company participated in the 2026 national medical insurance negotiation bidding with multiple Chinese patent medicines; YUNJI, which was included in Stock Connect on September 7, plunged 16.44%, with the company obtaining its entry ticket less than 11 months after listing.

I. Market Overview

On the market, among Hong Kong Stock Connect constituents, amid accelerated AI iteration, XIZHI TECH-P surged 19.19%, STAR SHINE HLDG surged 16.91%, and ANDRE JUICE surged 14.78%; SHINEWAY PHARM surged 11.38%, as the company participated in the 2026 national medical insurance negotiation bidding with multiple Chinese patent medicines. On the downside, YUNJI, which was included in Stock Connect on September 7, plunged 16.44%; the company obtained its entry ticket less than 11 months after listing. The medical theme pulled back, with TH MEDICAL-B plunging 15.46%.

Southbound funds recorded a net purchase of 3.720 billion HKD on the day. Of this, Hong Kong Stock Connect (Shanghai) recorded net purchases of 2.817 billion HKD, and Hong Kong Stock Connect (Shenzhen) recorded net purchases of 904 million HKD.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Gainers No. 1	01879.HK	XIZHI TECH-P	19.19	371.400	5.99
Gainers No. 2	01440.HK	STAR SHINE HLDG	16.91	11.340	1.13
Gainers No. 3	02218.HK	ANDRE JUICE	14.78	26.400	1.75
Gainers No. 4	02225.HK	JINHAI MED TECH	13.00	6.475	1.82
Gainers No. 5	02877.HK	SHINEWAY PHARM	11.38	8.300	0.50
Decliners No. 5	06681.HK	BRAINAURORA-B	-10.25	1.270	0.25
Decliners No. 4	06872.HK	TENNOR THERAP-B	-10.30	149.800	0.20
Decliners No. 3	00917.HK	QUNABOX GROUP	-10.69	7.850	0.96
Decliners No. 2	02697.HK	TH MEDICAL-B	-15.46	293.000	0.26
Decliners No. 1	02670.HK	YUNJI	-16.44	87.150	0.45

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	06869.HK	YOFC	60.81	-2.12	7.24
2	00100.HK	MINIMAX-W	37.54	-2.37	-3.14
3	02513.HK	Z.AI	27.77	-3.87	-0.27
4	00700.HK	TENCENT	26.43	2.66	-0.32
5	01888.HK	KB LAMINATES	25.42	-2.92	4.76
6	00883.HK	CNOOC	20.69	4.51	-0.15
7	09888.HK	Baidu Group-W	17.79	17.35	2.96
8	00981.HK	SMIC	15.92	-2.25	-0.54
9	09988.HK	ALIBABA-W	12.59	4.38	0.27
10	06166.HK	CIG	10.70	2.09	-1.82

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Gainers No. 1	159266	Maxwealth CSI HK Equities Central Enterprise Dividends ETF	1.11	0.11
Gainers No. 2	159333	Wanjia CSI HK Equities Central Enterprise Dividends ETF	1.08	0.09
Gainers No. 3	526060	Huatai-PB CSI HK Equities Information Technology Integration ETF	1.03	0.32
Gainers No. 4	520990	Invesco Great Wall CSI Guoxin HK Equities Central Enterprise Dividends ETF	0.99	0.83
Gainers No. 5	520660	China Southern CSI Guoxin HK Equities Central Enterprise Dividends ETF	0.99	0.69
Decliners No. 5	520740	Huaan CSI HK Equities Internet ETF	-2.55	0.07
Decliners No. 4	159297	China Southern CNI HK Equities Innovative Drugs ETF	-2.56	1.38
Decliners No. 3	520650	China Southern CSI HK Equities Internet ETF	-2.56	0.69
Decliners No. 2	159570	China Universal CNI HK Equities Innovative Drugs ETF	-2.65	14.84
Decliners No. 1	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	-3.94	3.68

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	14.84	6.74	-2.65
2	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	13.84	3.99	-2.48
3	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (HKD)	11.75	56.97	0.73
4	159567	Yinhua CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	5.91	8.10	-2.25
5	159316	E Fund Hang Seng HK Innovative Drugs ETF	Hang Seng HK Innovative Drugs Index	5.29	8.61	-2.14
6	513750	GF CSI HK Connect Financials (ex Banks) Thematic ETF	CSI HK Connect Financials (ex Banks) Thematic Index (RMB)	4.94	4.00	-0.39
7	513190	ChinaAMC CSI HK Equities Interior Finance ETF	CSI HK Equities Interior Finance Index (HKD)	4.73	25.60	0.00
8	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	4.26	6.17	-2.43
9	526000	ChinaAMC CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (HKD)	3.95	189.77	0.85
10	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	Hang Seng HK Equities Innovative Drugs And Health Care Index	3.68	10.96	-3.94

IV. Industry and Corporate Updates

1. ASCLETIS-B (01672.HK) Initiates Phase I Study in the US of Oral Amylin Receptor Agonist Peptide ASC36 for the Treatment of Obesity

On September 9, ASCLETIS-B (01672.HK) announced the initiation in the US of a Phase I study of the oral amylin receptor agonist peptide ASC36 for the treatment of obesity, -19-14. ASCLETIS was newly included in the Hong Kong Stock Connect and as a constituent of the Hang Seng Composite Index on September 7.

2. NEW VISION CO Wins Model Designation from a Leading International German Automaker for the First Time

NEW VISION CO (02632) disclosed on September 9 that the company has won a model designation from a leading international German automaker for the first time. NEW VISION CO is mainly engaged in the R&D and supply of products related to in-vehicle displays and smart cockpits, and this designation is the first time it has obtained a vehicle model project from this German automaker. The company's shares have been included in the list of Hong Kong Stock Connect target securities under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect since September 7, 2026, and eligible mainland investors can already trade its shares through the Hong Kong Stock Connect channel. NEW VISION CO is one of the newly added targets in this round of the regular adjustment of Hong Kong Stock Connect targets.

3. JINHAI MED TECH Discloses Interim Results, with Minimally Invasive Medical Business Revenue Growing 301.5%

JINHAI MED TECH (02225) disclosed its 2026 interim results after being included in the list of Hong Kong Stock Connect targets on September 7: revenue in the first half of the year was SGD 34.021 million, up 134.2% year-on-year; the loss narrowed to SGD 3.63 million, compared with SGD 10.80 million in the same period last year; the gross margin rose from 14.3% to 19.5%. The company said that during the period, its minimally invasive medical business grew 301.5% year-on-year. The company's revenue scale and profit level are still in a ramp-up stage, and this is the first disclosure of interim operating data after its inclusion in the Hong Kong Stock Connect list.

4. KINWONG and TAOTAO Pass HKEX Main Board Listing Hearing

According to HKEX's disclosure on September 7, Shenzhen Kinwong Electronic Co., Ltd. (603228.SH) and Zhejiang Taotao Vehicles Co., Ltd. (301345.SZ) have passed the HKEX Main Board listing hearing. The prospectus shows that KINWONG is a manufacturer of PCB products, serving customers in fields such as automotive electronics, communications and data infrastructure, smart devices, and industrial control; TAOTAO is a supplier of outdoor leisure and electric mobility solutions, with products sold to more than 90 countries and regions. The two companies correspond to the two tracks of hard-tech manufacturing and cross-border consumer going global respectively, and their H-share issuance and listing still need to complete the subsequent placing and listing procedures.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

NewTimeSpace HK Stock Connect HK Stock Connect ETF